Decision Tools
Use StartEnhance's smartest planning tools before the CTA
Estimate cost, compare the two featured GLP-1 paths, and figure out which page to read first before you move into provider review.
Planning Tool
Estimate first-month and multi-month GLP-1 spend using StartEnhance's current starting prices, then pressure-test shipping, support, and one-time intake fees before you click away.
- Model semaglutide and tirzepatide with StartEnhance's current homepage starting prices.
- Add shipping, support, or intake fees to see first-month and ongoing cost more clearly.
- Move directly into the medication page that best fits your budget posture.
Comparison Tool
Compare StartEnhance's two featured GLP-1 pathways side by side on starting price, positioning, and next-step fit without bouncing between commercial pages.
- See semaglutide and tirzepatide in one table instead of piecing the comparison together manually.
- Switch the recommendation based on affordability, premium intent, or uncertainty.
- Jump from the table into the exact solution page or comparison hub that matches your situation.
Screening Tool
Answer a few non-clinical questions about budget, readiness, and decision friction to see which StartEnhance page makes the most sense to open next.
- Uses a short decision flow to route visitors without implying clinical approval.
- Separates cost, trust, and medication-fit questions instead of blending them together.
- Keeps the final medical decision with the independent provider where it belongs.
Use the tools first, then click with context
These tools are built to clarify cost, medication fit, and readiness. They do not replace provider review, and they do not change the fact that independent licensed providers make the medical decision.
StartEnhance is not a medical provider. Eligibility, diagnosis, treatment, prescribing, shipping, and follow-up are handled by independent licensed healthcare providers and pharmacy partners.